Postmarket Safety Surveillance of Delayed Complications for Recent FDA-Approved Hyaluronic Acid Dermal Fillers

To review postmarketing data for delayed (≥14 days post-treatment) adverse events (AEs) of interest (inflammatory and noninflammatory nodules, hypersensitivity, granulomas) for newer hyaluronic acid (HA) fillers FDA-approved within the last 5 years (2016–2020). METHODS: Reports from the Manufacturer...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Joel L., Hicks, Jessica, Nogueira, Alessandra, Lane, Vanessa, Andriopoulos, Bill
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806034/
https://www.ncbi.nlm.nih.gov/pubmed/34935756
http://dx.doi.org/10.1097/DSS.0000000000003350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806034/
https://www.ncbi.nlm.nih.gov/pubmed/34935756
http://dx.doi.org/10.1097/DSS.0000000000003350

Ejemplares similares